Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2-3% of the global population. The condition is characterized by red, scaly patches that impact the quality of a patient’s life and can sometimes be life-threatening.
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy
Lilly’s Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide 1 (GLP-1) receptor agonist while Novo’s Wegovy is a GLP-1 receptor agonist.
December 4, 2024